文献速递神经肿瘤

高级别胶质瘤监测期影像学评估时间表的参数模型研究

Radiological assessment schedule for high-grade glioma patients during the surveillance period using parametric modeling.
PubMed 文献 · Neuro Oncol · 2021-01-01

研究基于277例完成标准治疗的高级别胶质瘤患者(178例GBM,99例AA),按遗传特征和残留病灶分层,利用分段指数生存模型拟合PFS曲线,以观察期剩余患者10%进展率为标准确定最佳影像评估时间点,为各风险分层提出个体化MRI随访方案。

要点

  • IDH野生型GBM:标准治疗结束后每7.4周MRI至120周,后22周拐点期,之后每27.6周。
  • IDH突变型GBM:每13.2周MRI至151周;IDH野生型AA每22.8周,IDH突变型AA每41.2周至241周。
  • 基于PFS参数模型可为GBM和AA各风险分层制定个体化影像评估时间表。

核心结论

  • 基于PFS参数模型可为高级别胶质瘤各风险分层患者确定最佳影像学评估时间表。

研究设计与样本

  • 单中心回顾性队列研究,纳入277例完成标准治疗的高级别胶质瘤患者(178例GBM,99例AA)。
  • 按遗传特征和残留病灶或递归分割分析进行风险分层,采用分段指数生存模型估计PFS曲线。

主要发现

  • IDH野生型GBM最佳MRI随访间期为每7.4周至标准治疗结束后120周,随后22周拐点期,之后每27.6周。
  • IDH突变型GBM推荐每13.2周扫描至151周。
  • IDH野生型AA最佳随访间期为每22.8周,IDH突变型AA为每41.2周至241周。

关键数值与推荐

  • 以每个观察期剩余患者中10%进展率作为确定最佳影像评估时间点的标准。

临床怎么用

  • 可根据患者IDH状态和风险分层参考相应MRI随访间期制定监测计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An optimal radiological surveillance plan is crucial for high-grade glioma (HGG) patients, which is determined arbitrarily in daily clinical practice. We propose the radiological assessment schedule using a parametric model of standardized progression-free survival (PFS) curves. METHODS: A total of 277 HGG patients (178 glioblastoma [GBM] and 99 anaplastic astrocytoma [AA]) from a single institute who completed the standard treatment protocol were enrolled in this cohort study and retrospectively analyzed. The patients were stratified into each layered risk group by genetic signatures and residual mass or through recursive partitioning analysis. PFS curves were estimated using the piecewise exponential survival model. The criterion of a 10% progression rate among the remaining patients at each observation period was used to determine the optimal radiological assessment time point. RESULTS: The optimal follow-up intervals for MRI evaluations of isocitrate dehydrogenase (IDH) wild-type GBM was every 7.4 weeks until 120 weeks after the end of standard treatment, followed by a 22-week inflection period and every 27.6 weeks thereafter. For the IDH mutated GBM, scans every 13.2 weeks until 151 weeks are recommended. The optimal follow-up intervals were every 22.8 weeks for IDH wild-type AA, and 41.2 weeks for IDH mutated AA until 241 weeks. Tailored radiological assessment schedules were suggested for each layered risk group of the GBM and the AA patients. CONCLUSIONS: The optimal schedule of radiological assessments for each layered risk group of patients with HGG could be determined from the parametric model of PFS.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Ji SY, Lee J, Lee JH, et al. Radiological assessment schedule for high-grade glioma patients during the surveillance period using parametric modeling. Neuro Oncol. 2021. PMID: 33130858. doi:10.1093/neuonc/noaa250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。